The CHARITE Artificial Disc: design history, FDA IDE study results, and surgical technique.

نویسنده

  • Fred H Geisler
چکیده

INTRODUCTION Lumbar fusion serves to eliminate abnormal motion and instability at symptomatic degenerated levels, subsequently reducing or eliminating low back pain in patients with degenerative disc disease (DDD). Reported clinical outcomes for these procedures vary widely. A meta-analysis of lumbar fusion procedures performed by Geisler et al.10 demonstrated the elimination of lumbar segmental motion that resulted in a significant reduction in pain and subsequent improvement in disability level. Fusion is successful in many cases because the abnormal motion itself is the root cause of pain. When the segment is fused, it no longer moves and cannot, therefore, cause pain. Fusion, however, can result in stress and increased motion in the segments adjacent to the fused level, as demonstrated by Cunningham et al.6 This may initiate and/or accelerate the degenerative disease process in adjacent segments. Reported rates of adjacent-level disease requiring reoperation after lumbar fusion range from 20 to 35%.11,12 The inherent problem with surgical arthrodesis of the degenerative lumbar segment is that it merely masks the true disease process by eliminating the intervertebral motion and its normal physiological function.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Complications of Lumbar Artificial Disc Replacement Compared to Fusion: Results From the Prospective, Randomized, Multicenter US Food and Drug Administration Investigational Device Exemption Study of the Charité Artificial Disc

BACKGROUND Previous reports of lumbar total disc replacement (TDR) have described significant complications. The US Food and Drug Administration (FDA) investigational device exemption (IDE) study of the Charité artificial disc represents the first level I data comparison of TDR to fusion. METHODS In the prospective, randomized, multicenter IDE study, patients were randomized in a 2:1 ratio, w...

متن کامل

Surgical Treatment for Discogenic Low-Back Pain: Lumbar Arthroplasty Results in Superior Pain Reduction and Disability Level Improvement Compared With Lumbar Fusion

BACKGROUND The US Food and Drug Administration approved the Charité artificial disc on October 26, 2004. This approval was based on an extensive analysis and review process; 20 years of disc usage worldwide; and the results of a prospective, randomized, controlled clinical trial that compared lumbar artificial disc replacement to fusion. The results of the investigational device exemption (IDE)...

متن کامل

The Incidence of Potential Candidates for Total Disc Replacement among Lumbar and Cervical Fusion Patient Populations

STUDY DESIGN Retrospective chart review. PURPOSE To evaluate the incidence of potential total disc replacement (TDR) candidates among cervical and lumbar fusion patient populations using strict Food and Drug Administration (FDA) criteria and with relative exclusion criteria removed. OVERVIEW OF LITERATURE Recent studies suggest that the potential percentage of patients that are candidates f...

متن کامل

Design of an Elastic Arthroplastic Disc Optimized under Different Loads

Introduction: Due to limitations of current treatments for degenerative disc disease, arthroplastic methods to repair the diseased disc have been proposed. The artificial disc is a mobile implant for degenerative disc replacement that attempts to lessen the degeneration of the adjacent elements following interbody fusion procedures. Because the success of artificial disc replacement depends on ...

متن کامل

The First 18 Months Following Food and Drug Administration Approval of Lumbar Total Disc Replacement in the United States: Reported Adverse Events Outside an Investigational Device Exemption Study Environment

BACKGROUND Introduction of a new surgical technology may result in higher rates of adverse events compared with rates reported in the study performed to gain regulatory approval. The purpose of our study was to describe the incidence of reported adverse events during the first 18 months following US Food and Drug Administration (FDA) approval of the first lumbar arthroplasty device available in...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Clinical neurosurgery

دوره 53  شماره 

صفحات  -

تاریخ انتشار 2006